Advance Agrolife IPO
- aditya hujband
- Oct 2, 2025
- 2 min read

Company Overview:
Advance Agrolife Limited, incorporated in 2002, is an Indian agrochemical company engaged in the manufacturing, formulation, and distribution of a wide range of crop protection and agro-support products.
The company’s portfolio covers insecticides, herbicides, fungicides, plant growth regulators, fertilizers (micro-nutrients and bio-fertilizers), and technical grade products used in agriculture.
Advance Agrolife serves farmers, agro-based industries, and corporates through a strong B2B sales model, operating across 19 states and 3 union territories in India, while also exporting to UAE, Bangladesh, China (incl. Hong Kong), Turkey, Egypt, Kenya, and Nepal.
The company has three manufacturing facilities located in Jaipur, Rajasthan, with integrated capabilities enabling scale and cost efficiency.
Objects of the Issue:
Funding working capital requirements – ₹135 Cr
General corporate purposes & miscellaneous – ₹57.86 Cr
Strengths:
Wide product portfolio across agrochemicals, fertilizers & technical products
Strong domestic presence with growing exports
In-house R&D driving innovation & compliance
Scalable manufacturing with backward integration
Demand supported by agri-growth & food security trends
B2B model ensures long-term corporate relationships
Adherence to global regulatory & quality standards
Expanding export potential in Asia, Africa & Middle East
Year-round demand with coverage of Kharif & Rabi crops
Risks:
Seasonal & monsoon-dependent demand
Stringent environmental & regulatory norms
Intense competition from global & domestic players
Raw material and forex price volatility
High working capital requirements
Exposure to export trade & geopolitical risks
Dependence on distribution networks & credit cycles
Risk from bio-based/organic alternatives
Advance Agrolife IPO: Key Details
IPO Dates: 30 – 3 Oct 2025
Price Band: ₹95 to ₹100 per share
Lot Size: 150 Shares
Total Issue Size: ₹192.86 Cr
Retail Quota: 35%
GMP (for reference only): ~12%
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matters published here are purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader making decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website.



Comments